Sensitivity to change of the Brief Psychiatric Rating Scale-Extended (BPRS-E): An item and subscale analysis.

Burlingame, Gary M.; Seaman, Scott A.; Johnson, Jennifer E.; Whipple, Jason L.; Richardson, Elizabeth; Rees, Frank; Earnshaw, Dallas; Spencer, Richard G.; Payne, Mark; O’Neil, Brock

doi:10.1037/1541-1559.3.2.77

Cited by 49 publications

(27 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The BRPS is a clinician-rated scale measuring 24 different psychiatric symptoms, each rated on a 7-point scale, ranging from 1 ( not present ) to 7 ( extremely severe ). It is a reliable and valid measure of psychiatric symptoms (35), and has previously been administered to assess psychotic-like symptoms in injecting drug users (36). Masters- and PhD-qualified clinical psychologists administered the BPRS.…”

Section: Methodsmentioning

confidence: 99%

Polysubstance Use in Cannabis Users Referred for Treatment: Drug Use Profiles, Psychiatric Comorbidity and Cannabis-Related Beliefs

Connor¹,

Gullo²,

Chan³

et al. 2013

Front. Psychiatry

View full text Add to dashboard Cite

Background: Population-based surveys demonstrate cannabis users are more likely to use both illicit and licit substances, compared with non-cannabis users. Few studies have examined the substance use profiles of cannabis users referred for treatment. Co-existing mental health symptoms and underlying cannabis-related beliefs associated with these profiles remains unexplored.Methods: Comprehensive drug use and dependence severity (Severity of Dependence Scale-Cannabis) data were collected on a sample of 826 cannabis users referred for treatment. Patients completed the General Health Questionnaire, Cannabis Expectancy Questionnaire, Cannabis Refusal Self-Efficacy Questionnaire, and Positive Symptoms and Manic-Excitement subscales of the Brief Psychiatric Rating Scale. Latent class analysis was performed on last month use of drugs to identify patterns of multiple drug use. Mental health comorbidity and cannabis beliefs were examined by identified drug use pattern.Results: A three-class solution provided the best fit to the data: (1) cannabis and tobacco users (n = 176), (2) cannabis, tobacco, and alcohol users (n = 498), and (3) wide-ranging substance users (n = 132). Wide-ranging substance users (3) reported higher levels of cannabis dependence severity, negative cannabis expectancies, lower opportunistic, and emotional relief self-efficacy, higher levels of depression and anxiety and higher manic-excitement and positive psychotic symptoms.Conclusion: In a sample of cannabis users referred for treatment, wide-ranging substance use was associated with elevated risk on measures of cannabis dependence, co-morbid psychopathology, and dysfunctional cannabis cognitions. These findings have implications for cognitive-behavioral assessment and treatment.

show abstract

Section: Methodsmentioning

confidence: 99%

Polysubstance Use in Cannabis Users Referred for Treatment: Drug Use Profiles, Psychiatric Comorbidity and Cannabis-Related Beliefs

Connor¹,

Gullo²,

Chan³

et al. 2013

Front. Psychiatry

View full text Add to dashboard Cite

show abstract

“…Some analysis also included: disorientation, self-neglect, mannerism and posturing, and uncooperativeness. Dingenmans et al found a moderate internal consistency for their BPRS-E four-component scales with Cronbach's alpha ranging from 0.76 (depression scale) to 0.64 (mania scale), while Burlingame et al [18] demonstrated its sensitive to change.…”

Section: The Brief Psychiatric Rating Scale (Bprs)mentioning

confidence: 99%

Psychometric evaluation of the negative syndrome of schizophrenia

García-Portilla

Álvarez

Sáiz

et al. 2015

Eur Arch Psychiatry Clin Neurosci

View full text Add to dashboard Cite

In this paper, we reviewed the available instruments for assessing the negative syndrome of schizophrenia, describing their strengths and weaknesses. Current instruments were classified into two categories according to their content validity and assessment approach as first- or second-generation instruments. The BPRS, SANS, the SENS and the PANSS belong to the first generation, while the BNSS, the CAINS and the MAP-SR belong to the second generation. The NSA can be considered a transitional instrument between the two. First-generation instruments have more content validity problems than second-generation instruments do, as they do not accurately reflect the currently accepted negative syndrome (they do not include all negative symptoms and signs or they include symptoms from other dimensions). They also have more problems relative to the use of behavioural referents instead of internal experiences of deficits when assessing symptoms, which may lead to measuring functioning instead of negative symptoms. Further research needs to be done in this area in order to ensure the evaluation of primary negative symptoms and internal experiences involved in negative symptoms rather than external behaviours.

show abstract

“…2004). Also Burlingame et al. (2006) mention that the usefulness of BPRS‐E as a repeat measure for persistently mentally ill population is underscored.…”

Section: Assessment Of Existing Scalesmentioning

confidence: 99%

“…The symptoms experienced by severely disturbed patients are usually chronic in nature hence any scale measuring them must be sensitive enough to detect changes. To our knowledge, one study measuring sensitivity of change for the more recent BRRS versions (BPRS‐E) among varying patient populations indicates that 22 of the 24 items of the BPRS‐E, all its four factors and the total score are sensitive to change (high internal consistency validity) (Burlingame et al. 2006).…”

Section: Assessment Of Existing Scalesmentioning

confidence: 99%

See 1 more Smart Citation

The measurement of psychotic acuity by nursing staff

Theodoridou

Bowers

Brennan

et al. 2009

Psychiatric Ment Health Nurs

View full text Add to dashboard Cite

Accurate evaluation of patients' psychotic state is essential to decrease psychotic symptoms and protect the patient and others. The aim of this paper is to conduct a literature review in order to access the utility, reliability and validity of current rating scales that are purported to measure psychotic acuity of inpatient population. A search of a number of electronic databases was undertaken to retrieve potential articles that focus on the measurement of acute psychosis. We identified some conceptual and theoretical problems when using a scale that is monitoring the progress of discharge and assesses the outcome of treatments. The findings revealed a difficulty in finding a commonly agreed definition of acute psychosis and a problem of obtaining frequent measures, and the frequency of measurement and fluctuation in psychosis. The most dominant scales in assessing psychosis were reviewed: the Global Assessment of Functioning Scale, the Brief Psychiatric Rating Scale and the Positive and Negative Symptom Scale. Several issues related to the scales' inter-rater reliability and construct validity remain unexplored. None of these scales addressed the conceptual and theoretical problems that we identified. A new scale that will measure acuity of symptoms in inpatient settings needs to be created.

show abstract

Sensitivity to change of the Brief Psychiatric Rating Scale-Extended (BPRS-E): An item and subscale analysis.

Cited by 49 publications

References 31 publications

Polysubstance Use in Cannabis Users Referred for Treatment: Drug Use Profiles, Psychiatric Comorbidity and Cannabis-Related Beliefs

Polysubstance Use in Cannabis Users Referred for Treatment: Drug Use Profiles, Psychiatric Comorbidity and Cannabis-Related Beliefs

Psychometric evaluation of the negative syndrome of schizophrenia

The measurement of psychotic acuity by nursing staff

Contact Info

Product

Resources

About